These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39155759)

  • 1. Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes.
    Bor WLW; Azzahhafi J; Maio ND; van der Sangen NMR; Verburg A; Rayhi S; Peper J; Chan Pin Yin DRPP; Ten Berg JM
    EuroIntervention; 2024 Aug; 20(16):996-1007. PubMed ID: 39155759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.
    Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK;
    Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological therapy following acute coronary syndromes in patients with atrial fibrillation: how do we balance ischaemic risk with bleeding risk?
    Fake AL; Harding SA; Matsis PP; Larsen PD
    N Z Med J; 2016 May; 129(1435):39-49. PubMed ID: 27355167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.
    Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C
    BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand's COOL-AF registry.
    Winijkul A; Kaewkumdee P; Yindeengam A; Krittayaphong R
    BMC Cardiovasc Disord; 2021 Mar; 21(1):117. PubMed ID: 33653277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation.
    Mai L; Wu Y; Luo J; Liu X; Zhu H; Zheng H; Liang G; Zhang Y; Huang Y
    BMJ Open; 2019 Sep; 9(9):e031180. PubMed ID: 31530618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticoagulant therapy in atrial fibrillation with acute coronary syndrome in real clinical practice according to the total register of acute coronary syndrome in the Krasnodar Territory].
    Tatarintseva ZG; Kosmachyeva ED; Porhanov VA
    Kardiologiia; 2018 SJul; 58(S7):55-64. PubMed ID: 30081803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics, management and outcomes of patients with acute coronary syndrome and atrial fibrillation: real-world data from two nationwide registries in Italy.
    Lucà F; Caretta G; Vagnarelli F; Marini M; Iorio A; Di Fusco SA; Pozzi A; Gabrielli D; Colivicchi F; De Luca L; Gulizia MM
    J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):99-105. PubMed ID: 31923052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.
    Zeymer U; Annemans L; Danchin N; Pocock S; Newsome S; Van de Werf F; Medina J; Bueno H
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):121-129. PubMed ID: 29611427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
    Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG;
    Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.
    Jackson LR; Piccini JP; Cyr DD; Roe MT; Neely ML; Martinez F; Lüscher TF; Lopes RD; Winters KJ; White HD; Armstrong PW; Fox KA; Prabhakaran D; Bhatt DL; Magnus Ohman E; Corbalán R
    Clin Cardiol; 2016 Sep; 39(9):497-506. PubMed ID: 27468086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of oral anticoagulation in atrial fibrillation patients after acute ischaemic stroke and outcome after 3 months: results of the multicentre Berlin Atrial Fibrillation Registry.
    Olma MC; Tütüncü S; Hansen K; Grittner U; Kunze C; Dietzel J; Schurig J; Dimitrijeski B; Hagemann G; Hamilton F; Honermann M; Jungehuelsing GJ; Kauert A; Koennecke HC; Mackert BM; Nabavi DG; Schmehl I; Sparenberg P; Stingele R; Voelzke E; Waldschmidt C; Zeise-Wehry D; Heuschmann PU; Endres M; Haeusler KG
    Open Heart; 2024 Sep; 11(2):. PubMed ID: 39299734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis and antithrombotic practice patterns in patients with recurrent and transient atrial fibrillation following acute coronary syndrome: A nationwide study.
    Petersen JK; Butt JH; Yafasova A; Torp-Pedersen C; Sørensen R; Kruuse C; Vinding NE; Gundlund A; Køber L; Fosbøl EL; Østergaard L
    Int J Cardiol; 2024 Jul; 407():132017. PubMed ID: 38588863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.
    Steinberg BA; Kim S; Piccini JP; Fonarow GC; Lopes RD; Thomas L; Ezekowitz MD; Ansell J; Kowey P; Singer DE; Gersh B; Mahaffey KW; Hylek E; Go AS; Chang P; Peterson ED;
    Circulation; 2013 Aug; 128(7):721-8. PubMed ID: 23861512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality.
    Pyka Ł; Hudzik B; Bartuś S; Buszman P; Gierlotka M; Wojakowski W; Hiczkiewicz J; Kleinrok A; Skrzypek M; Kuliczkowski W; Gąsior M
    J Cardiovasc Pharmacol Ther; 2023; 28():10742484231212106. PubMed ID: 38158229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study.
    Ahn HJ; Lee SR; Choi J; Lee KY; Kwon S; Choi EK; Oh S; Lip GYH
    Europace; 2024 Feb; 26(2):. PubMed ID: 38290433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
    Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH;
    Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events).
    Worme MD; Tan MK; Armstrong DWJ; Yan AT; Tan NS; Brieger D; Budaj A; Gore JM; López-Sendón J; Van de Werf F; Steg PG; Fox KAA; Goodman SG; Udell JA
    Am J Cardiol; 2018 Sep; 122(6):944-951. PubMed ID: 30115426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
    Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-discharge antithrombotic management and clinical outcomes of patients with new-onset or pre-existing atrial fibrillation and acute coronary syndromes undergoing coronary stenting: Follow-up data of the MATADOR-PCI study.
    De Luca L; Di Lenarda A; Rubboli A; Bolognese L; Gonzini L; Fortuni F; Navazio A; Poletti F; Ledda A; Urbinati S; Gabrielli D; Gulizia MM;
    Eur J Intern Med; 2021 Jun; 88():28-34. PubMed ID: 33838988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.